DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 124 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,456 | +22.8% | 822 | +35.9% | 0.00% | – |
Q2 2023 | $8,518 | -8.9% | 605 | 0.0% | 0.00% | – |
Q1 2023 | $9,347 | -27.8% | 605 | -23.4% | 0.00% | – |
Q4 2022 | $12,948 | +1194.8% | 790 | +1419.2% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 52 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | – | 52 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 52 | +126.1% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 23 | +53.3% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 15 | -21.1% | 0.00% | – |
Q4 2019 | $1,000 | – | 19 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $18,687,872 | 15.44% |
Redmile Group, LLC | 5,582,105 | $86,243,522 | 3.74% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,218,638 | $80,627,957 | 1.80% |
BRAIDWELL LP | 3,241,351 | $50,078,873 | 1.65% |
Parkman Healthcare Partners LLC | 491,772 | $7,597,877 | 1.65% |
Sunesis Advisors, LLC | 96,299 | $1,487,820 | 1.07% |
ARMISTICE CAPITAL, LLC | 4,100,000 | $63,345,000 | 0.91% |
Deep Track Capital, LP | 1,363,201 | $21,061,455 | 0.86% |
AlphaCentric Advisors LLC | 72,500 | $1,120,125 | 0.77% |
Ikarian Capital, LLC | 174,510 | $2,696,179 | 0.61% |